Researchers have demonstrated the difference between the cancer of the appendix and colon cancer, a distinction that could lead to more effective treatments for both diseases.
The study by Edward A. Levine, M.D., professor of surgery and chief of the surgical oncology service at Wake Forest Baptist, is the result of gene analysis of cases covering a 10-year period.
Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
Advertisement
It appears in the early online edition of the April issue of the Journal of the American College of Surgeons.Cancer of the appendix, which is part of the colon, affects approximately 2,500 people in the United States annually and has the propensity to spread throughout the peritoneal cavity, the space within the abdomen that contains the intestines, stomach and liver.
"Our treatment program, which was the catalyst for this research, is one of the largest worldwide and consists of aggressive surgery coupled with heated chemotherapy placed directly into the abdominal cavity at the time of surgery," Levine said.
![Appendectomy - Animation]( "Appendectomy - Animation")
Slides and animation of Appendicitis and Appendectomy by both Open and Laparoscopic surgical methods.
"Given the uncertainty of predicting outcomes in patients with disseminated appendiceal cancer, we sought to use the tools of gene expression profiling to better understand these rare malignancies at a molecular level in order to better predict oncologic outcomes.
We've looked at the genes that make these cancers tick, and we actually started to pick them apart for the first time."For the study, the researchers examined tumor samples from Wake Forest Baptist's tissue bank for patterns of expression of different genes.
"By looking at these genetic signatures, we found that the genes active in cancer of the colon and those active in cancer of the appendix are very different," Levine said. "For years, however, cancer of the appendix, which is part of the colon, has been treated with the same chemotherapy treatment used for colon cancer.
This study shows that we need a fresh approach to how we treat appendix cancer."
Source: Eurekalert
Appendectomy - Animation
Slides and animation of Appendicitis and Appendectomy by both Open and Laparoscopic surgical methods.
Advertisement
"Given the uncertainty of predicting outcomes in patients with disseminated appendiceal cancer, we sought to use the tools of gene expression profiling to better understand these rare malignancies at a molecular level in order to better predict oncologic outcomes.
We've looked at the genes that make these cancers tick, and we actually started to pick them apart for the first time."For the study, the researchers examined tumor samples from Wake Forest Baptist's tissue bank for patterns of expression of different genes.
"By looking at these genetic signatures, we found that the genes active in cancer of the colon and those active in cancer of the appendix are very different," Levine said. "For years, however, cancer of the appendix, which is part of the colon, has been treated with the same chemotherapy treatment used for colon cancer.
This study shows that we need a fresh approach to how we treat appendix cancer."
Source: Eurekalert
Appendicitis
Appendicitis is inflammation of the appendix with intense, migrating abdominal pain caused by obstruction due to tumors, feces, or infection.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
